Alliance Growers Corp. (CSE:ACG, FWB:1LA, OTCQB:ALGWF), reports expansion of the Company’s business model beyond the cannabis sector.
Alliance Growers Corp. (CSE:ACG, FWB:1LA, OTCQB:ALGWF) (“Alliance Growers” or “the Company), reports expansion of the Company’s business model beyond the cannabis sector. Alliance Growers has expanded its consistent strategy of providing products and services to cultivators to providing some of the same products and services beyond the cannabis sector to the entire agri-food, industry specifically those that require in-line disinfection and clean processing equipment.
With the addition of the HOCl exclusive distribution component as well as the organic fertilizer component, the Company has extended its reach to include customers beyond the cannabis space, not limited to providing tissue cultured plantlets and other related services to cannabis cultivators only.
The Company is in the final stages of securing a Canada wide exclusive master franchise agreement to sell, market and over see several turn-key organic waste management/organic fertilizer franchises that will provide services to cultivators and to the entire agri-food, industry specifically those that require inline disinfection and clean processing equipment. As part of the process, this system uses the Black Soldier Fly Larvae to not only convert organic waste to produce an organic fertilizer, but also to create valuable products that can be sold into a number of different sectors which will provide Alliance with additional revenue streams.
Alliance Growers will be working closely with a highly experienced team to market, sell and set-up franchise operations across North America and in select countries globally to implement the waste management/organic fertilizer systems. The franchise model provides Alliance Growers with multiple revenue streams from franchise fees, service fees, consumables and sales to other industries with the byproducts created in the process. The initial sales team has been established and the marketing plan is in the final stages of completion.
“Expanding our business model to reach other industries beyond the cannabis space is an efficient way to achieve revenues on a larger scale and make Alliance stand out from other junior cannabis companies” Commented Dennis Petke, President and CEO of Alliance Growers. “Given the current environment in the cannabis space, we realize that cannabis companies must show investors that they have near term revenue that is realistic and sustainable. We are not changing our business model we are expanding on it. Other cannabis companies have begun to chase the next big thing like edibles, various CBD products and infused beverage products, but we are staying on course providing products and services to cultivators and beyond. Alliance will simultaneously go forward with its plans to provide medical cannabis to countries like Germany where there is high demand though our farm-in arrangement in Africa.
About Alliance Growers Corp.
Alliance Growers is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Biotech Complex (products and services to cultivators), Strategic Investments in Cannabis Cultivators, CBD Oil Supply and Distribution, and Research and Technology.
Alliance Growers is working with Pharmagreen Biotech Inc. to jointly develop and operate a 63,000- square foot Cannabis Biotech Complex, to be the first of its kind in Western Canada to house a DNA Botany lab, CBD extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general.
For further information, please visit the Company’s website at www.alliancegrowers.com or the Company’s profile at www.sedar.com.
If you would like to be added to Alliance Growers’ news distribution list, please send your email address to firstname.lastname@example.org.
For more information contact:
CEO, President and Director
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forwardlooking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.